ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 2.0.24 - 2999001/03565638CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120240410W172 73deBibliographieenBibliographyfrBibliographieEP18700385.0201801052019071720200710enenen201762443508 P20170106US2024041020241520191113201946202403062024102023091820240410202415A61K 47/65 20170101AFI20230317BHEP A61P 35/00 20060101ALI20230317BHEP A61K 47/64 20170101ALI20230317BHEP A61K 38/08 20190101ALI20230317BHEP C07K 7/56 20060101ALI20230317BHEP A61K 47/65 20170801 LI20180309BHEP A61P 35/00 20180101 LI20180719BHEP A61K 47/64 20170801 FI20180719BHEP A61K 38/08 20130101 LI20201222RHEP C07K 7/56 20130101 LI20191119BHEP deBIZYKLISCHE KONJUGAT ZUR BEHANDLUNG VON KREBSenBICYCLE CONJUGATE FOR TREATING CANCERfrCONJUGUÉ BICYCLIQUE POUR TRAITER LE CANCERWO-A1-2010/089115WO-A1-2013/050615WO-A1-2016/067035WO-A1-2017/191460GU GUANGZHI ET AL: "The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells", BIOMATERIALS, vol. 34, no. 21, 2013, pages 5138-5148, XP028593827, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2013.03.036BENNETT, GavinCambridge, CB21 6GSGBTEUFEL, Daniel PaulCambridge, CB21 6GSGBBicycleRD Limited102032717N426934EPBlocks A & B Portway Building Granta Park Great AbingtonCambridge, CB21 6GSGBJ A Kemp LLP10166966680 Turnmill StreetLondon EC1M 5QUGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRGB201805001720180105enWO201812769920180712201828